Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip navigation

A trial looking at MRI scans to pick up early signs of prostate cancer pressing on the spine (PROMPTS)

This trial is looking at using magnetic resonance imaging (MRI) to pick up early signs that prostate cancer is starting to press on the spine. This trial is supported by Cancer Research UK.

Sometimes prostate cancer can spread to the backbone (spine). This can cause pressure on the long bundle of nerves in the backbone (the spinal cord). Doctors call this spinal cord compression. The symptoms of spinal cord compression include pain and numbness. People with spinal cord compression need to have treatment quickly to relieve the pressure.

Doctors often use an MRI scan to confirm any symptoms of spinal cord compression. The researchers think that MRI scans may be used to find early signs of spinal cord compression before symptoms happen. This means treatment can start earlier, which may prevent the most severe symptoms.

The aim of this trial is to see if MRI scans can be used to find early signs of spinal cord compression before you have any symptoms.

Recruitment

Start 26/02/2013
End 26/07/2015

Phase

Phase 3

Who can enter

You may be able to enter this trial if

You cannot enter this trial if

  • Your cancer has spread to your brain
  • You are taking daily painkillers for back pain caused by your cancer spread
  • You already have spinal cord compression or any other nerve damage
  • You have had radiotherapy or surgery to treat or prevent spinal cord compression – if you had radiotherapy to relieve pain in your spine caused by your cancer spread and now have no symptoms you may take part in this trial
  • You have had an MRI scan of your spine in the past year
  • You have had a CT scan or PET-CT scan of both your chest and tummy (abdomen) in the past 6 months
  • You are planned to have a MRI scan or CT scan of your chest or tummy (abdomen)
  • You have had another cancer in the past 5 years apart from basal cell carcinoma and early bladder cancer that is not likely to spread (low grade)
  • You are not able to have an MRI scan because for example you have a pacemaker or other metal in your body, or you cannot lie flat for at least 1 hour

Trial design

This is a phase 3 trial. It will recruit 541 men. It is a randomised trial. The people taking part are put into 1 of 2 groups by a computer. Neither you nor your doctor will be able to decide which group you are in.

The men in group 1 will continue to be seen as usual. If you develop signs or symptoms of spinal cord compression you will receive treatment.

The men in group 2 will have a MRI scan. If this shows early signs of spinal cord compression you will have treatment. You then have a MRI scan every 6 months. If the scan doesn’t show signs of spinal cord compression you will see your doctor as usual.

PROMPTS trial diagram

The trial team will ask you to fill out a questionnaire when you agree to take part in this trial and then every 3 months for 3 years. The questionnaire will ask about side effects and how you’ve been feeling. This is called a quality of life study.

If you develop early signs of spinal cord compression the team will ask you to fill out another questionnaire about 3 months after your treatment.

Hospital visits

You see the doctor to have some tests before taking part in this trial. These tests include

  • A physical examination
  • Blood tests
  • PSA test

After agreeing to take part, the men in group 2 will have a MRI scan.

You see the doctor every 3 months for 2 years and then every 6 months for a year.

Side effects

MRI scan is a safe test and the researchers don’t anticipate any side effects.

You can find more information about MRI scans in our cancer tests section.

Location of trial

For more information

Please note: we cannot help you to join a specific trial. Unless we state otherwise in this trial summary, you need to print this page and take it to your own doctor to discuss.

Find out how to join a trial or contact our cancer information nurses for other questions about cancer by phone (0808 800 4040), by email, or at

The Information Nurses
Cancer Research UK
Angel Building
407 St John Street
London
EC1V 4AD

Chief Investigator

Professor David Dearnaley

This is Cancer Research UK trial number CRUK/11/053.

Supported by

Cancer Research UK
Institute of Cancer Research (ICR)
National Institute for Health Research Cancer Research Network (NCRN)
The Royal Marsden NHS Foundation Trust
Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 12 March 2014